医学
临床试验
内科学
多不饱和脂肪酸
胃肠病学
脂肪酸
内分泌学
药理学
二十碳五烯酸
脂肪组织
作者
Yufeng Chen,Sunjeong Bae,Kai Wang,Mengxi Du,Yujia Lu,Qi Sun,Perry A. Labelle,Alexander Caraballo,Kylor H. Lachut,Alina Husain,Liza A. Hote,Madeline Koehn,Elizabeth Prezioso,Trenton Reinicke,Madeline M. Schuck,Janavi Sethurathnam,Julia R. Solowey,Jacqueline Elise Woo,Peter J. Carolan,Daniel C. Chung
标识
DOI:10.1016/j.ajcnut.2026.101419
摘要
BACKGROUND: Icosapent ethyl (IPE), an ethyl ester of eicosapentaenoic acid (EPA; C20:5n-3), is thought to have immunomodulatory properties and may protect against colorectal cancer. OBJECTIVES: This study aimed to assess the effect of IPE on changing total marine omega-3 (n-3) polyunsaturated fatty acid (PUFA) and individual fatty acid composition in colorectal tissue. METHODS: We conducted a prospective, single-arm clinical trial of 4 g/d IPE (VASCEPA) treatment for 8 to 12 wk among patients with a recent history of adenoma. We collected pretreatment and posttreatment colorectal biopsies through flexible sigmoidoscopy and participants' diet and lifestyle via questionnaires. The primary outcome was the change in total marine ω-3 PUFA in colorectal tissue measured by gas-liquid chromatography. We examined changes in individual fatty acids exploratorily. RESULTS: Among a total of 81 patients enrolled, 72 had paired pretreatment and posttreatment tissue fatty acid data. After intervention, the tissue composition [median (interquartile range)] of total marine ω-3 PUFA increased from 2.10% (0.96%) to 5.21% (1.97%), with a fold change of 2.40 (0.82). With a slight decrease in ω-6 PUFA [fold change = 0.96 (0.27)], the ratio of marine ω-3 to ω-6 PUFA increased [fold change = 2.58 (0.81)]. Among individual fatty acids, EPA increased the most [fold change = 5.88 (3.63)]. The cumulative amount of IPE treatment, rather than daily dosage, showed a positive correlation with changes in tissue EPA composition (Spearman's ρ = 0.23, P = 0.051). The treatment effect on tissue EPA changes appeared to be stronger for participants with lower than higher dietary EPA intake at baseline, although the interaction tests did not reach statistical significance (P for interaction = 0.26). CONCLUSIONS: IPE treatment substantially increased incorporation of marine ω-3 PUFA, particularly EPA, into the colorectal tissue while reducing tissue ω-6 PUFA composition. This trial was registered at clinicaltrials.gov as NCT04216251.
科研通智能强力驱动
Strongly Powered by AbleSci AI